Kezar Life Sciences Inc. (NASDAQ: KZR)
$7.5450
-0.0750 ( +0.60% ) 21.4K
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Market Data
Open
$7.5450
Previous close
$7.6200
Volume
21.4K
Market cap
$55.38M
Day range
$7.3100 - $7.6200
52 week range
$5.2020 - $11.3500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | May 09, 2024 |
| def | Proxies and info statements | 17 | Apr 26, 2024 |
| ars | Annual reports | 1 | Apr 26, 2024 |
| pre | Proxies and info statements | 17 | Apr 16, 2024 |
| 8-k | 8K-related | 13 | Mar 14, 2024 |
| 10-k | Annual reports | 96 | Mar 14, 2024 |
| 3 | Insider transactions | 2 | Jan 17, 2024 |
| 4 | Insider transactions | 1 | Jan 09, 2024 |
| 4 | Insider transactions | 1 | Jan 09, 2024 |
| 8-k | 8K-related | 10 | Jan 08, 2024 |